nni-362
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2019 (NCT04074837)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Ribosomal protein S6 kinase 1ACTIVATOR
RPS6KB1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04074837 | Phase 1 | Aug 1, 2019 | National Institute on Aging (NIA), Neuronascent, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2019 |
| Neuronascent, Inc. | For profit | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1